Formosa and Medvisis agree on post-operative eye pain therapy
Formosa Pharmaceuticals in Taiwan has signed an exclusive licensing agreement with Medvisis Switzerland to commercialise clobetasol propionate ophthalmic suspension, 0.05% (APP13007), for post-operative inflammation and pain after ocular surgery. The …